https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24248 Wed 16 Nov 2016 17:03:47 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33336 Tue 03 Sep 2019 17:59:43 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39023 Thu 21 Apr 2022 09:51:00 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25668 Sat 24 Mar 2018 07:28:05 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23605 Sat 24 Mar 2018 07:13:29 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38564 P < 0.0001). The majority indicated they would be ‘quite a bit’ or ‘very much’ interested in future live virtual meetings. Conclusion: The TROG 2020 ASM was conducted as a live virtual meeting. Participant satisfaction and future interest in a live virtual meeting was high, indicating this is a viable platform for other CCTG’s faced with the decision to deliver virtual content at times of global public health threats.]]> Mon 29 Jan 2024 17:56:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38984 9/L and FENO ≤29 ppb. Exacerbations requiring medical intervention were recorded. Results: Among 220 non-smokers (n = 109 control, n = 111 FENO), 1006 treatment decisions were made, with significant group differences after the first and second algorithm applications. 53% of women had NEA. Treatment was better targeted to phenotype in the FENO group: ICS use increased in eosinophilic asthma (EA, 48–86%), while ICS/LABA increased in NEA (11–30%). Fewer women in the FENO group had exacerbations during pregnancy in NEA only (18.9% FENO vs 44% control, P = 0.006). Conclusion: The FENO algorithm was more effective in treating NEA, resulting in reduced exacerbations, compared to a symptom control algorithm. This was not the result of ICS overtreatment, since the benefits occurred at a lower median daily ICS dose. Two applications of the FENO-guided algorithm, one month apart, were sufficient to achieve beneficial effects in terms of asthma exacerbations, among pregnant women with asthma.]]> Mon 29 Jan 2024 17:52:03 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37924 Fri 02 Jul 2021 10:59:52 AEST ]]>